Factors Affecting Burden of Psychopharmacological Medication in Patients with Autism Spectrum Disorder: The Importance of Early Diagnosis

The mean age at diagnosis of patients taking psychotropic medication was significantly higher than that of the patients who were not taking psychotropic medication (t=-3.064; p

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objective: The aim of the present study is to specify the frequency in psychopharmacological medication use in children with autism spectrum disorder (ASD) and determine their age range at diagnosis.

📊

Key Findings & Data:Sami Ulus Maternity and Children Research and Training Hospital between 2010 -2015 were reviewed retrospectively.

💡

Conclusion & Impact:The mean age at diagnosis of patients taking psychotropic medication was significantly higher than that of the patients who were not taking psychotropic medication (t=-3.064; p

🔬Design:Review & Systematic Survey

📍Scope:2010 -2015 Verileri

⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the present study is to specify the frequency in psychopharmacological medication use in children with autism spectrum disorder (ASD) and determine their age range at diagnosis. Methods: Five hundred and twenty three children with ASD who applied to Dr. Sami Ulus Maternity and Children Research and Training Hospital between 2010 -2015 were reviewed retrospectively. Data has been obtained from computerized hospital information system. Individuals with the diagnosis of Autism (F84.0), Atypical Autism (F84.1) and Pervasive Developmental Disorder Not Other Specified (F84.9) were screened. Results: Psychotropic medication was recommended to 28.5% of the 523 children and adolescents diagnosed with ASD. Antipsychotics were the most common drugs of choice among psychotropic medications. The mean age at diagnosis of patients taking psychotropic medication was significantly higher than that of the patients who were not taking psychotropic medication (t=-3.064; p

🔖

Cite This Article

BODUR, Ş., TASKİRAN, C., ISİLDAR, Y., ALAN, B. E., CETİNKAYA, M., KARA, H., SAHİN, M., TURGUT, S. (2022). Factors Affecting Burden of Psychopharmacological Medication in Patients with Autism Spectrum Disorder: The Importance of Early Diagnosis. Klinik Psikofarmakoloji Bülteni, Cilt: 26 - Sayı: 3, 273–277. https://ajindex.com/articles/573880

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet 2014;383(9920):896-910. [CrossRef]2. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 2014;28;63(2):1-21.3. Anagnostou E, Zwaigenbaum L, Szatmari P, Fombonne E, Fernandez BA, Woodbury-Smith M, et al. Autism spectrum disorder: advances in evidence-based practice. CMAJ 2014;15;186(7):509-19.4. Monteiro SA, Spinks-Franklin A, Treadwell-Deering D, Berry L, Sellers-Vinson S, Smith E, et al. Prevalence of Autism Spectrum Disorder in Children Referred for Diagnostic Autism Evaluation. Clin Pediatr (Phila) 2015;54(14):1322-7. [CrossRef] 5. Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res 2009;65(6):591-8. [CrossRef]6. Fombonne E, Quirke S, Hagen A. Epidemiology of pervasive developmental disorders. In Amaral D, Dawson G, Geschwind D, eds. Autism Spectrum Disorders. New York: Oxford University Press; 2011. p. 90-111. [CrossRef]7. Lai MC, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry 2015;54(1):11-24. [CrossRef]8. Volkmar FR, Wiesner LA. Autism and Related Disorders. In: Carey EB, Crocker AC, Coleman WL, Elias ER, Feldman HM, eds. Developmental-Behavioral Pediatrics, 4th edn. Philadelphia: Saunders; 2009:675-85. [CrossRef]9. Costanzo V, Chericoni N, Amendola FA, Casula L, Muratori F, Scattoni ML, et al. Early detection of autism spectrum disorders: From retrospective home video studies to prospective 'high risk' sibling studies. Neurosci Biobehav Rev 2015;55:627-35. [CrossRef]10. Zwaigenbaum L, Bryson S, Garon N. Early identification of autism spectrum disorders. Behav Brain Res 2013;15;251:133-46. [CrossRef]11. Kleinman JM, Robins DL, Ventola PE, Pandey J, Boorstein HC, Esser EL, et al. The modified checklist for autism in toddlers: a follow-up study investigating the early detection of autism spectrum disorders. J Autism Dev Disord 2008;38(5):827-39. [CrossRef]12. Chlebowski C, Robins DL, Barton ML, Fein D. Large-scale use of the modified checklist for autism in low-risk toddlers. Pediatrics 2013;131(4):e1121-7. [CrossRef]13. Zwaigenbaum L, Bauman ML, Fein D, Pierce K, Buie T, Davis PA, et al. Early Scre